An isothiocyanate derived from glucoraphanin powerful antioxidant, anti-inflammatory, and anti-carcinogenic effects at 40 µM, activates Nrf2-mediated gene expression of phase II detoxification enzymes by disrupting the Keap1-Nrf2 complex,
An isothiocyanate derived from glucoraphanin powerful antioxidant, anti-inflammatory, and anti-carcinogenic effects at 40 µM, activates Nrf2-mediated gene expression of phase II detoxification enzymes by disrupting the Keap1-Nrf2 complex,
Lauric acid leelamide is the lauric (C-12) amide analog of leelamine. Leelamine has weak affinity for the human CB1 and CB2 receptors, exhibiting 20% displacement of [3H]-CP55940 at a concentration of 10 µM.
Lauric acid leelamide is the lauric (C-12) amide analog of leelamine. Leelamine has weak affinity for the human CB1 and CB2 receptors, exhibiting 20% displacement of [3H]-CP55940 at a concentration of 10 µM.
An oxidized metabolite of sulindac that is produced in many mammals but minimally in mice and rats generally considered to be inactive against COX enzymes, although it can reduce azoxymethane-induced colon cancer in rats inhibits aldose reductase
An oxidized metabolite of sulindac that is produced in many mammals but minimally in mice and rats generally considered to be inactive against COX enzymes, although it can reduce azoxymethane-induced colon cancer in rats inhibits aldose reductase
A hydrophobic bile acid formed in the liver by conjugation of lithocholate with taurine induces apoptosis in hepatocytes at 75 µM used to experimentally induce cholestasis.
A hydrophobic bile acid formed in the liver by conjugation of lithocholate with taurine induces apoptosis in hepatocytes at 75 µM used to experimentally induce cholestasis.
Lauric acid leelamide is the lauric (C-12) amide analog of leelamine. Leelamine has weak affinity for the human CB1 and CB2 receptors, exhibiting 20% displacement of [3H]-CP55940 at a concentration of 10 µM.
Lauric acid leelamide is the lauric (C-12) amide analog of leelamine. Leelamine has weak affinity for the human CB1 and CB2 receptors, exhibiting 20% displacement of [3H]-CP55940 at a concentration of 10 µM.
An oxidized metabolite of sulindac that is produced in many mammals but minimally in mice and rats generally considered to be inactive against COX enzymes, although it can reduce azoxymethane-induced colon cancer in rats inhibits aldose reductase
An oxidized metabolite of sulindac that is produced in many mammals but minimally in mice and rats generally considered to be inactive against COX enzymes, although it can reduce azoxymethane-induced colon cancer in rats inhibits aldose reductase